Metformin, a first-line T2DM treatment, affects the gastrointestinal tract by altering glucose uptake, GLP-1 secretion, gut microbiota, and immune response [33, 34], but it rarely causes bowel obstruction
2 FerrauFKorbonitsM
Management of skin sensitivity during semaglutide therapy requires a systematic approach that addresses both local injection site reactions and any reported systemic symptoms
Gastrointestinal adverse effects represent the most frequently reported side effects of semaglutide therapy, with rates varying by dose, formulation, and indication
While bathroom issues can be a side effect of poor gut health, a less obvious problem is prolonged high blood sugar (i.e., diabetes)
Poor sleep can worsen glucose tolerance and insulin sensitivity, creating a constant loop of fatigue